Mesenchymal Stem Cell Applications in Regenerative Medicine

Mesenchymal stem cells (MSCs) are multipotent stromal cells capable of differentiating into bone, cartilage, adipose and other mesodermal lineages under appropriate conditions. Beyond direct differentiation, MSCs exert potent immunomodulatory and trophic effects via secretion of bioactive molecules and extracellular vesicles, collectively known as the secretome. These paracrine factors support angiogenesis, recruit endogenous progenitors and mitigate inflammation, making MSCs attractive candidates for cell‐based therapies in orthopaedics, cardiovascular repair, autoimmune disorders and wound healing. Sources such as bone marrow, adipose tissue and umbilical cord offer varying proliferation rates and functional profiles. Advances in scaffold design, delivery methods and genetic engineering have improved MSC engraftment and survival in preclinical models. Clinical translation has progressed to hundreds of trials, exploring both autologous and allogeneic approaches, with growing interest in cell‐free therapeutics derived from conditioned media or exosomes. Together, these developments underscore the global significance of MSCs as versatile tools for tissue regeneration and immunotherapy.

Research from Nature Portfolio

Recent clinical evaluation of induced pluripotent stem cell‐derived MSCs demonstrated long‐term safety and tolerability in patients with steroid‐resistant acute graft‐versus‐host disease. Intravenous infusion of a standardised MSC product was associated with no serious adverse events or tumour formation over a two‐year follow‐up, and survival rates compared favourably with historical controls. These findings support the feasibility of scalable, off‐the‐shelf MSC therapies for immune‐mediated disorders and establish a foundation for larger efficacy trials.

Mesenchymal Stem Cell Applications in Regenerative Medicine publication trend

The graph below shows the total number of articles in mesenchymal stem cell applications in regenerative medicine across all publications each year (not limited to Nature Index journals).

Technical terms

Mesenchymal stem cell (MSC): A multipotent stromal cell capable of differentiating into bone, cartilage, adipose and other mesodermal lineages while exerting immunomodulatory and trophic effects.

Induced pluripotent stem cell (iPSC): A somatic cell reprogrammed to a pluripotent state, capable of generating various specialised cell types including MSCs.

Secretome: The collection of bioactive molecules and extracellular vesicles secreted by cells that mediate paracrine signalling.

Paracrine signalling: Cell–cell communication via secreted factors that influence neighbouring cells without direct contact.

Graft-versus-host disease (GvHD): An immune-mediated complication in which donor immune cells attack recipient tissues following allogeneic transplantation.

References

1. Characterization of mesenchymal stem cells in human fetal bone marrow by single-cell transcriptomic and functional analysis. Signal Transduction and Targeted Therapy (2023).
2. Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease. Nature Medicine (2024).
3. Mesenchymal stem cell perspective: cell biology to clinical progress. npj Regenerative Medicine (2019).
4. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. International Journal of Molecular Sciences (2017).
5. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Communication and Signaling (2011).
6. Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing. PLOS ONE (2008).